A Novel Inhibitor of Homodimerization Targeting MyD88 Ameliorates Renal Interstitial Fibrosis by Counteracting TGF-β1-Induced EMT in Vivo and in Vitro
Background/Aims: The TLR/MyD88/NF-κB signaling pathway has been successfully used to treat renal interstitial fibrosis (RIF). However, the exact therapeutic mechanism is still unknown. Here, we assessed the therapeutic efficacy of TJ-M2010-2, a small molecular compound that inhibits MyD88 homodimeri...
Saved in:
Main Authors: | Jian-Hua Liu (Author), Long He (Author), Zhi-Miao Zou (Author), Zuo-Chuan Ding (Author), Xue Zhang (Author), Hao Wang (Author), Ping Zhou (Author), Lin Xie (Author), Shuai Xing (Author), Cheng-Zhi Yi (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2018-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts
by: Junbin Chen, et al.
Published: (2020) -
IL-37 Suppresses MyD88-mediated Inflammatory Responses in Human Aortic Valve Interstitial Cells
by: Qiong Zhan, et al.
Published: (2017) -
Effect of Alpina oxyphylla extract on streptozotocin-induced kidney injure via regulating TGF-β1 and MyD88
by: Jiao-xia Wu, et al.
Published: (2020) -
MyD88 deficiency ameliorates weight loss caused by intestinal oxidative injury in an autophagy‐dependent mechanism
by: Ming Qi, et al.
Published: (2022) -
MyD88 signalling is critical in the development of pancreatic cancer cachexia
by: Xinxia Zhu, et al.
Published: (2019)